Valuation Ocugen, Inc. Börse Stuttgart

Stocks

Real-time Estimate Tradegate 10:00:07 2026-09-03 EDT			5-day change	1st Jan Change
1.131 ^EUR	-0.44%		-5.80%	-10.90%

09-01	Ocugen Doses First Patient in Trial of Potential Eye Disease Drug	MT
09-01	Ocugen Doses First Patient in Phase 3 Registrational Trial of Ocu410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	906.3	284.6	147.5	234.5	421.6	447.6	-	-
Change	-	-68.6%	-48.17%	59%	79.79%	6.16%	-	-
Enterprise Value (EV)	906.3	284.6	147.5	234.5	421.6	447.6	447.6	447.6
Change	-	-68.6%	-48.17%	59%	79.79%	6.16%	0%	0%
P/E	-15.2x	-3.42x	-2.21x	-4.03x	-5.87x	-5.08x	-4.71x	-40.6x
PBR	-	-	-	-	-	-	-	-
PEG	-	-0.1x	0.1x	0.2x	-0.4x	-0.4x	-0.61x	0.5x
Capitalization / Revenue	-	-	24.4x	57.8x	95.5x	94.1x	179x	3.07x
EV / Revenue	-	-	0x	0x	0x	94.1x	179x	3.07x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-6.18x	-5.09x	-152x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.3	-0.38	-0.26	-0.2	-0.23	-0.26	-0.28	-0.0325
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	6.036	4.055	4.413	4.757	2.5	145.7
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-58.03	-84.87	-65.53	-54.76	-62.92	-72.48	-87.98	-2.941
Net income ¹	-58.36	-81.35	-63.08	-54.05	-67.85	-87.21	-97.94	-12.92
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	4.550	1.300	0.575	0.805	1.350	1.320	1.320	1.320
Nbr of stocks (in thousands)	199,186	218,887	256,502	291,320	312,320	339,110	-	-
Announcement Date	2/25/22	2/28/23	4/16/24	3/5/25	3/4/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
LONZA GROUP AG	34.07x	6.11x	18.29x	0.94%	50.14B
REVOLUTION MEDICINES, INC.	-21.38x	253.2x	-23.09x	-.--%	44.85B
IQVIA HOLDINGS INC.	33.98x	3.29x	14.19x	-.--%	43.43B
BEONE MEDICINES AG	47.39x	5.49x	30x	-.--%	41.14B
CELLTRION, INC.	28.29x	8.56x	21.63x	0.41%	32.92B
MEDPACE HOLDINGS, INC.	33.72x	5.52x	25.09x	-.--%	16.55B
EUROFINS SCIENTIFIC SE	24.26x	2.11x	9.12x	1.11%	14.65B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	78.05x	4.1x	15.91x	-.--%	13.93B
Average	32.30x	36.05x	13.89x	0.31%	32.2B
Weighted average by Cap.	27.59x	48.49x	12.48x	0.3%